Showing results (231-240 of 610) with videos related to

Sort By:
Pageof 61
Therapeutics and Clinical Risk Management|March 25, 2008
Treatment of pruritic diseases with topical calcineurin inhibitorsSonja Ständer, Funda Schürmeyer-Horst, Thomas A Luger, et al.
Annals of the New York Academy of Sciences|May 19, 2000
Molecular basis of the alpha-MSH/IL-1 antagonismT Brzoska, D H Kalden, T Scholzen, et al.
Annals of the New York Academy of Sciences|May 19, 2000
Mechanisms of the antiinflammatory effects of alpha-MSH. Role of transcription factor NF-kappa B and adhesion molecule expressionD H Kalden, T Scholzen, T Brzoska, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 22, 2000
alpha-melanocyte-stimulating hormone as a mediator of tolerance inductionT A Luger, D Kalden, T E Scholzen, et al.
Investigative Ophthalmology & Visual Science|December 1, 1982
Corneal epithelial cell--derived thymocyte-activating factor (CETAF)G Grabner, T A Luger, G Smolin, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 6, 2007
Successful treatment of generalized eruptive histiocytoma with PUVAH Lan Ma, Dieter Metze, Thomas A Luger, et al.
Diabetologia|September 17, 2009
Beta cell (dys)function in non-diabetic offspring of diabetic patientsM Stadler, G Pacini, J Petrie, et al.
The Journal of Experimental Medicine|February 1, 1986
Characterization of a monoclonal antibody directed against the biologically active site of human interleukin 1A Köck, M Danner, B M Stadler, et al.
Pageof 61